| NASDAQ (usa) | 
    	      | 
    6715.56 | -12.11 | -0.18% | 
| FTSE 100 (london) | 
	![]()  | 
    7487.96 | -5.12 | -0.07% | 
| DAX (german) | 
	      | 
    13465.51 | 235.94 | 1.78% | 
| NIKKEI 225 (japan) | 
	      | 
    22420.08 | 408.47 | 1.86% | 
| Hang - Seng (hong kong) | 
	      | 
    28594.06 | 348.52 | 1.23% | 
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) | 
	      | 
    3391.61 | 17.53 | 0.52% | 
| KOSPI (korea) | 
	      | 
    2556.47 | 33.04 | 1.31% | 
| All Ordinaries (australia) | 
	      | 
    6005.30 | 28.90 | 0.48% | 
| BOVESPA (brazil) | 
	      | 
    74092.76 | -215.73 | -0.29% | 
PharmaEngine Inc (TWO: 4162)
                                    	4162 Technical Analysis
                                    
                                    
    5
    
    
    
    
									| As on 3rd Nov 2025 4162 STOCK Price closed @ 70.50 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 95.09 & Strong Sell for SHORT-TERM with Stoploss of 94.98 we also expect STOCK to react on Following IMPORTANT LEVELS. | 
4162STOCK Price
| Open | 72.40 | Change | Price | % | 
| High | 72.40 | 1 Day | -0.60 | -0.84 | 
| Low | 70.30 | 1 Week | 1.50 | 2.17 | 
| Close | 70.50 | 1 Month | 6.10 | 9.47 | 
| Volume | 642538 | 1 Year | -22.10 | -23.87 | 
| 52 Week High 120.50 | 52 Week Low 64.40 | ||||
    TWO Taiwan Most Active Stocks
                    | 1815 | 76.00 | 5.26% | 
| 3264 | 101.00 | 8.02% | 
| 4991 | 175.00 | -4.11% | 
| 5371 | 91.00 | 3.88% | 
| 8111 | 58.30 | -5.20% | 
| 6173 | 64.60 | 9.86% | 
| 6274 | 388.50 | 0.78% | 
| 5498 | 24.75 | 3.99% | 
| 3105 | 118.00 | 9.77% | 
| 5381 | 26.10 | 9.89% | 
TWO Taiwan Top Gainers Stocks
                    
                TWO Taiwan Top Losers Stocks
                    
                | 4162 Daily Charts  | 
                4162 Intraday Charts  | 
                Whats New @  Bazaartrend  | 
                4162 Free Analysis  | 
              
| 
                
                 | 
              
4162 Important Levels Intraday
                                    | RESISTANCE | 74.55 | 
| RESISTANCE | 73.25 | 
| RESISTANCE | 72.45 | 
| RESISTANCE | 71.64 | 
| SUPPORT | 69.36 | 
| SUPPORT | 68.55 | 
| SUPPORT | 67.75 | 
| SUPPORT | 66.45 | 
4162 Forecast  November 2025
                                    | 4th UP Forecast | 88.81 | 
| 3rd UP Forecast | 82.94 | 
| 2nd UP Forecast | 79.31 | 
| 1st UP Forecast | 75.68 | 
| 1st DOWN Forecast | 65.32 | 
| 2nd DOWN Forecast | 61.69 | 
| 3rd DOWN Forecast | 58.06 | 
| 4th DOWN Forecast | 52.19 | 
     4162 Weekly Forecast
                                    
                                    
                                | 4th UP Forecast | 81.87 | 
| 3rd UP Forecast | 78.22 | 
| 2nd UP Forecast | 75.97 | 
| 1st UP Forecast | 73.72 | 
| 1st DOWN Forecast | 67.28 | 
| 2nd DOWN Forecast | 65.03 | 
| 3rd DOWN Forecast | 62.78 | 
| 4th DOWN Forecast | 59.13 | 
4162 Forecast2025
                                    | 4th UP Forecast | 184.39 | 
| 3rd UP Forecast | 147.86 | 
| 2nd UP Forecast | 125.29 | 
| 1st UP Forecast | 102.71 | 
| 1st DOWN Forecast | 38.29 | 
| 2nd DOWN Forecast | 15.71 | 
| 3rd DOWN Forecast | -6.86 | 
| 4th DOWN Forecast | -43.39 | 
                                        PharmaEngine Inc ( TWO Taiwan Symbol : 4162 ) 
Sector : Healthcare And Other Stocks in Same Sector
                                    
                                    
                                Sector : Healthcare And Other Stocks in Same Sector
4162 Other Details
                    | Segment | EQ | |
| Market Capital | 8285546496.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > echo $website ; ?> | |
4162 Address
                                 
                                         ![]()  | 
                                          ||
                                        4162 Latest News
                                    
                                    
                                    4162 Business Profile
   
	 PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer diseases in Taiwan and Europe. It is developing ONIVYDE for patients with gemcitabine-treated metastatic pancreatic cancer; PEP06, which is in Phase I stage for the treatment of cancer; and PEP07, an oral small molecule drug, which is in preclinical development stage to regulate DNA damage response. The company was founded in 2003 and is headquartered in Taipei, Taiwan. Address: 10 Minsheng East Road, Taipei, Taiwan, 104 
	
            
            © 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
 
	   Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

    
    